New CT rule-out examination cuts patient x-ray exposure
High radiation exposure has been the bogeyman keeping the cardiac CT triple rule-out exam for chest pain from widespread application.
High radiation exposure has been the bogeyman keeping the cardiac CT triple rule-out exam for chest pain from widespread application. The use of radiation dose reduction techniques addresses that concern.
Dr. Kevin Takakuwa and colleagues at Thomas Jefferson University reviewed data from 267 consecutive patients who underwent triple rule-out cardiac CT angiography after presenting to the emergency roon with symptoms of acute coronary syndrome. Ninety-five patients underwent the triple rule-out CTA protocol with tube current modulation, and 172 did so without it. Investigators found that patients undergoing triple rule-out without tube current modulation received average effective radiation doses of 18 mSv. Those getting the exam with tube current modulation, however, had effective radiation doses reduced by more than 50% without image quality loss. Findings were published in the American Journal of Roentgenology (2009;192[4]:866-872).
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
